Enzyme stalling method
US-2016010147-A1 · Jan 14, 2016 · US
US12168799B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12168799-B2 |
| Application number | US-202117496956-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 8, 2021 |
| Priority date | Jul 25, 2011 |
| Publication date | Dec 17, 2024 |
| Grant date | Dec 17, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a new method of sequencing a double stranded target polynucleotide. The two strands of the double stranded target polynucleotide are linked by a bridging moiety. The two strands of the target polynucleotide are separated using a polynucleotide binding protein and the target polynucleotide is sequenced using a transmembrane pore.
Opening claim text (preview).
The invention claimed is: 1. A method comprising: (i) preparing a nucleic acid construct by ligating a polynucleotide bridging moiety to a 3′ terminus of a first strand and a 5′ terminus of a second strand of a double stranded nucleic acid, wherein the first strand of the double stranded nucleic acid comprises a first nucleic acid sequence and the second strand of the double stranded nucleic acid comprises a second nucleic acid sequence that is complementary to the first nucleic acid sequence; (ii) using a single molecule sequencing apparatus to perform a sequencing reaction that reads through the first strand, the bridging moiety, and the second strand to produce orthogonal proof-reading sequence information for a methylated nucleobase in the first strand of the construct, wherein the movement of the nucleic acid construct through the single molecule sequencing apparatus is controlled by a Phi29 DNA polymerase; (iii) comparing the sequence information between the first nucleic acid sequence and the second nucleic acid sequence; and (iv) determining the presence of a methylated nucleobase in the first sequence. 2. The method of claim 1 , wherein the polynucleotide bridging moiety comprises a marker. 3. The method of claim 2 , wherein the marker is an abasic DNA or a sequence specific nucleic acids. 4. The method of claim 2 , wherein the method further comprising obtaining a signal from the marker in sequencing the bridging moiety that is indicative of the first strand having been sequenced. 5. The method of claim 1 , wherein the Phi29 DNA polymerase is not chemically modified. 6. The method of claim 1 , wherein the Phi29 DNA polymerase comprises an amino acid sequence at least 90% identical to SEQ ID NO: 6. 7. The method of claim 1 , wherein the preparing comprises synthesizing a complement of the first sequence to produce the double stranded nucleic acid, wherein the complement contains nucleobases selected from adenine, guanine, thymine, uracil, and cytosine. 8. The method of claim 1 , wherein the first nucleic acid sequence is present in a biological sample, wherein the biological sample is obtained or extracted from an organism or a microorganism. 9. The method of claim 1 , wherein the bridging moiety is a hairpin loop. 10. The method of claim 9 , wherein the hairpin loop is 4-100 nucleotides in length. 11. The method of claim 1 , wherein the hairpin loop is 4-8 nucleotides in length. 12. The method of claim 1 , wherein the first nucleic acid sequence is a DNA sequence. 13. The method of claim 1 , wherein the methylated nucleobase is 5-methylcytosine, 5-hydroxymethylcytosine, or methylcytidine. 14. The method of claim 1 , wherein the double-stranded nucleic acid comprises hemi-genomic DNA.
Microapparatus (sample containers with integrated microfluidic structures B01L3/5027) · CPC title
Arrangements for investigating the separated zones, e.g. localising zones · CPC title
Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68) · CPC title
Selection methods for production or design of target specific oligonucleotides or binding molecules · CPC title
Methods for sequencing · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.